GlassScriptPhysician profile
Eytan Keidar
NPI 1053846238
$6,906.95
in general payments reported to CMS, 2019-2025
24 companies · $2,769 in 2025
The $2,769 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $26.67 · 2021: $497 · 2022: $354 · 2023: $659 · 2024: $2,391 · 2025: $2,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,818.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,611.65 | 2023-2025 | Propel, Stealthstation S8 Platform, Nim Vital |
| Integra Lifesciences Corporation | $1,195.97 | 2023-2025 | Integra, Inspira Air, Acclarent Aera |
| Stryker Corporation | $636.82 | 2021-2025 | Xpress Loprofile, Scopis Ent, 1788 |
| Glaxosmithkline, LLC. | $542.03 | 2024-2025 | Nucala |
| Inspire Medical Systems, INC. | $500.97 | 2023-2025 | Inspire |
| Hologic Sales and Service, LLC | $331.84 | 2025 | Coolseal Generator |
| Optinose US, INC. | $230.38 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $200.15 | 2021-2025 | Dupixent |
| Aroa Biosurgery Incorporated | $176.51 | 2025 | |
| Neurent Medical Limited | $170.74 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Acera Surgical, INC. | $167.41 | 2024 | Restrata Wound Matrix |
| Genzyme Corporation | $156.19 | 2023-2025 | |
| Smith+Nephew, INC. | $149.29 | 2024 | Grafix Pl |
| Intersect Ent, INC. | $144.77 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $137.04 | 2025 | Neffy |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $118.12 | 2021 | |
| Ambu INC. | $113.21 | 2022 | |
| Aerin Medical INC. | $104.71 | 2019 | |
| Checkpoint Surgical, INC | $96.85 | 2022 | |
| Acclarent, INC | $47.02 | 2020-2023 | Acclarent Navwire |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.46 | 2022 | |
| Precigen, INC. | $19.28 | 2025 | |
| Alk-Abello, INC | $17.71 | 2023 | Grastek, Ragwitek, Odactra |
| Hikma Pharmaceuticals USA | $15.83 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eytan Keidar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.